Unlock the potential of biosimilars: Improve patient access and long-term healthcare sustainability

Temas de la conferencia
Since the world’s first biosimilar was approved in 2006, these treatments have had a positive impact on patient access and healthcare system sustainability. However, despite 15 years of progress, several challenges need to be addressed in order to unlock their full potential.

Organizador profesional (PCO)
Reuters Events

Mr. Josh Bramwell